Vascular Biogenics Ltd (NASDAQ:VBLT)

1.27
Delayed Data
As of Aug 03
 -0.05 / -3.82%
Today’s Change
0.90
Today|||52-Week Range
1.64
+6.25%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Vascular Biogenics Ltd have a median target of 3.38, with a high estimate of 5.00 and a low estimate of 2.50. The median estimate represents a +164.71% increase from the last price of 1.27.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Vascular Biogenics Ltd. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.14
Sales
$170.0K
Reporting Date
Aug 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 8.33%
 
 
 
 
 
 
Growthannually -0.46%
 
 
 
 
 
 

Sales

Growthquarterly -53.55%
 
 
 
 
 
 
Growthannually 42.62%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.